J&J COVID-19 vaccine in limbo in US

By Julie Steenhuysen and Manas Mishra
Updated April 15 2021 - 10:54am, first published 10:50am
The Johnson & Johnson COVID-19 vaccine has been paused in the US amid concerns over side effects.
The Johnson & Johnson COVID-19 vaccine has been paused in the US amid concerns over side effects.

Johnson & Johnson's COVID-19 vaccine remains in limbo in the United States as a health panel calls for more data before making a decision on how and whether to resume use of the one-dose shot.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options